A new approach for evaluating antigen-specific T cell responses to myelin antigens during the course of multiple sclerosis

被引:30
作者
Arbour, N
Holz, A
Sipe, JC
Naniche, D
Romine, JS
Zyroff, J
Oldstone, MBA
机构
[1] Scripps Res Inst, Dept Neuropharmacol, Div Virol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
[3] Scripps Clin, Div Neurol, La Jolla, CA USA
[4] Scripps Clin, Dept Radiol, La Jolla, CA USA
基金
加拿大健康研究院;
关键词
autoimmunity; central nervous system; T cell; self-antigen; flow cytometry;
D O I
10.1016/S0165-5728(03)00080-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We used a flow cytometry assay to measure proliferation and cytokine production of self-antigen-specific T cells in individual patients during the clinical course of multiple sclerosis (MS). Myelin-associated oligodendrocytic basic protein (MOBP) was selected for proof of principles in the assay, along with myelin basic protein (MBP) to assess specific activated T cells in 10 MS patients over an 18-month period, in parallel with brain magnetic resonance imaging (MRI) scans and clinical rating scale. A positive correlation occurred between antigen-specific T cell proliferation and interferon-gamma production with clinical relapses and MRI lesion activity that was. absent when the same patients were in remission. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:197 / 209
页数:13
相关论文
共 70 条
[51]   MULTIPLE-SCLEROSIS - CAPPING OF SURFACE IMMUNOGLOBULIN-G ON MACROPHAGES ENGAGED IN MYELIN BREAKDOWN [J].
PRINEAS, JW ;
GRAHAM, JS .
ANNALS OF NEUROLOGY, 1981, 10 (02) :149-158
[52]   TUMOR-NECROSIS-FACTOR-ALPHA MESSENGER-RNA EXPRESSION IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE-SCLEROSIS IS ASSOCIATED WITH DISEASE-ACTIVITY [J].
RIECKMANN, P ;
ALBRECHT, M ;
KITZE, B ;
WEBER, T ;
TUMANI, H ;
BROOCKS, A ;
LUER, W ;
HELWIG, A ;
POSER, S .
ANNALS OF NEUROLOGY, 1995, 37 (01) :82-88
[53]   A double-blind, placebo-controlled, randomized trial of cladribine in relapsing-remitting multiple sclerosis [J].
Romine, JS ;
Sipe, JC ;
Koziol, JA ;
Zyroff, J ;
Beutler, E .
PROCEEDINGS OF THE ASSOCIATION OF AMERICAN PHYSICIANS, 1999, 111 (01) :35-44
[54]  
SCHLUESENER HJ, 1985, J IMMUNOL, V135, P3128
[55]   IDENTIFICATION OF LYMPHOTOXIN AND TUMOR-NECROSIS-FACTOR IN MULTIPLE-SCLEROSIS LESIONS [J].
SELMAJ, K ;
RAINE, CS ;
CANNELLA, B ;
BROSNAN, CF .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (03) :949-954
[56]   TUMOR NECROSIS FACTOR MEDIATES MYELIN AND OLIGODENDROCYTE DAMAGE INVITRO [J].
SELMAJ, KW ;
RAINE, CS .
ANNALS OF NEUROLOGY, 1988, 23 (04) :339-346
[57]   CORRELATION OF INTERLEUKIN-2 AND SOLUBLE INTERLEUKIN-2 RECEPTOR WITH CLINICAL ACTIVITY OF MULTIPLE-SCLEROSIS [J].
SHARIEF, MK ;
THOMPSON, EJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1993, 56 (02) :169-174
[58]   Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system [J].
Steinman, L .
CELL, 1996, 85 (03) :299-302
[59]   Autoimmune pathogenesis of multiple sclerosis: Role of autoreactive T lymphocytes and new immunotherapeutic strategies [J].
Stinissen, P ;
Raus, J ;
Zhang, JW .
CRITICAL REVIEWS IN IMMUNOLOGY, 1997, 17 (01) :33-75
[60]   Multiple sclerosis: In situ evidence for antibody and complement-mediated demyelination [J].
Storch, MK ;
Piddlesden, S ;
Haltia, M ;
Iivanainen, M ;
Morgan, P ;
Lassmann, H .
ANNALS OF NEUROLOGY, 1998, 43 (04) :465-471